Accelerating Psychiatry Clinical Trials Through a Patient-Centric Approach: Real Patients, Real Outcomes

Life Sciences, Clinical Trials, Patient Recruitment & Retention,
  • Wednesday, October 30, 2024 | 10am EDT (NA) / 2pm GMT (UK) / 3pm CET (EU-Central)
  • 60 min

It is estimated that globally 1 in 8 individuals (2019 WHO figures) are affected by mental health problems, causing problems with all aspects of daily life. The personal, economic burden and associated increased risk in mortality underscore the need for the development of new and improved treatment options.

Clinical trials for psychiatry, including major depressive disorder, bipolar disorder, schizophrenia and generalized anxiety disorder, are unique and require an innovative and patient-centric approach to identification, enrollment and retention of suitable participants. This webinar will explore and discuss how to operationalize enrollment among a heterogenous group of participants, placebo response and its robust mitigation strategies to ensure a successful trial.

In this webinar, the expert speakers will explore the steps that can be made towards improving psychiatry trials, including recognizing the complexity of the population in protocol and trial design, understanding the patient’s journey to optimize patient recruitment and retention, increasing diversity and equality, minimizing bias and placebo response mitigation, patient and site education for consistency and accuracy and rater training and oversight.

Register now for the webinar to gain insights into strategies that can be followed for conducting successful psychiatry clinical trials.

Speakers

Dr. James Vornov, Medpace

Dr. James Vornov, MD, PhD, Vice President, Medical Department, Medpace

Dr. James Vornov is a board-certified Neurologist and internationally known Clinician-Scientist with over 18 years of neurology and psychiatry clinical development experience. At Medpace, he provides hands-on medical leadership to sponsors and internal study teams engaged in neuroscience clinical research.

He has worked in multiple neuroscience therapeutic areas and has directed programs related to depression, suicidal ideation, Parkinson’s disease, stroke, neuropathic pain, diabetic and chemotherapy-induced peripheral neuropathy, anesthesia and brain tumors.

Dr. Vornov received his BA in Biology from Columbia University and his MD and PhD from Emory University School of Medicine. He trained in Neurology at the Johns Hopkins Medical School where he served on the faculty for 10 years prior to transitioning to the industry.

Message Presenter
Ms. Jill Adkins, Medpace

Ms. Jill Adkins, Sr. Director, Clinical Trial Management, Medpace

Ms. Jill Adkins is an accomplished Clinical Research Professional with more than 24 years of experience working in the drug development industry across all study phases. She has over seven years of direct study management experience in psychiatry indications, including studies of controlled substances requiring close medication adherence monitoring and management.

At Medpace, Ms. Adkins is part of the Neuroscience Leadership Team and leads the Neuropsychiatry Working Group with a focus on implementing operational best practices for studies in psychiatry, sleep disorders and related indications.

Message Presenter
Ms. Daniela Rae, Medpace

Ms. Daniela Rae, MSc, RGN, IP, Advanced Clinical Practitioner, Medpace

Ms. Daniela Rae is an accomplished Consultant Nurse based in London, UK with nearly 2 decades of senior clinical, operational, and research leadership experience in neuroscience indications, specializing in neurodegenerative and neuropsychiatric disease. With extensive experience in assessing and managing complex psychiatric patients in both clinic and in clinical trial (Phase 1-3) settings, she contributes a unique patient-centric perspective at Medpace to support the medical and clinical operations team, as well as other functional areas.

She obtained her MSc in Public Health and Health Services Research from the University of Aberdeen in the United Kingdom and completed a prestigious Scottish Government Advanced Research Fellowship with a focus on neuropsychiatric disorders.

Message Presenter
Ms. Miaesha Campbell, Medpace

Ms. Miaesha Campbell, Sr. Director, Patient Recruitment, Medpace

Ms. Miaesha Campbell is an accomplished professional with over 17 years of experience directing a global team of strategic partners, support staff and vendors for multimillion-dollar global marketing, patient recruitment and patient retention campaigns. This includes oversight of the planning and execution of programs with a solution-based approach tailored to the needs of the sites and patients.  She has worked on studies across all phases and multiple therapeutic areas, using site and patient-centric strategies to bring clinical trials to patients as a care option.

Miaesha graduated from California State University at Dominquez Hills in May 2002, earning a Bachelor of Arts degree in English and a Minor in Communications. Her early career was spent in public relations, and she was recruited to support the marketing of clinical trial programs in 2007.

Message Presenter

Who Should Attend?

This webinar will appeal to VPs, Directors, Managers and Department Heads working within:

  • Clinical affairs
  • Clinical research
  • Clinical pharmacology
  • Clinical outsourcing
  • Project management
  • Regulatory affairs
  • Medical affairs

What You Will Learn

Join Medpace experts in this upcoming webinar as they explore:

  • Critical aspects and challenges of psychiatry clinical trials
  • Best practices for successfully conducting psychiatry trials
  • Importance of selecting the right patients for psychiatry trials
  • Strategies for protecting study endpoints
  • Tactics to support sites with recruitment and retention

Xtalks Partner

Medpace 

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account